Patents by Inventor Frederick W. BARR

Frederick W. BARR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CITRULLINE FOR TREATMENT OF SICKLE CELL CRISIS
    Publication number: 20220304966
    Abstract: A method for administration of citrulline for the treatment of sickle cell disease and other complications of sickle cell disease thereof.
    Type: Application
    Filed: June 3, 2022
    Publication date: September 29, 2022
    Inventors: Marshall L. SUMMAR, Frederick W. BARR, Suvankar MAJUMDAR
  • Citrulline for treatment of sickle cell crisis
    Patent number: 11351135
    Abstract: A method for administration of citrulline for the treatment of sickle cell disease and other complications of sickle cell disease thereof.
    Type: Grant
    Filed: February 27, 2018
    Date of Patent: June 7, 2022
    Assignees: VANDERBILT UNIVERSITY, THE UNIVERSITY OF MISSISSIPPI MEDICAL CENTER
    Inventors: Marshall L. Summar, Frederick W. Barr, Suvankar Majumdar
  • Sequelae of cardiopulmonary bypass-induced pulmonary injury
    Patent number: 10265286
    Abstract: A method for administering citrulline to a patient during surgery without filtration of the hemolysis to reduce the uncoupling of eNOS enzyme dimer that leads to cardiopulmonary bypass-induced pulmonary injury.
    Type: Grant
    Filed: December 22, 2017
    Date of Patent: April 23, 2019
    Assignee: Vanderbilt University
    Inventors: Marshall L. Summar, Frederick W. Barr
  • Citrulline for Treatment of Sickle Cell Crisis
    Publication number: 20180289647
    Abstract: A method for administration of citrulline for the treatment of sickle cell disease and other complications of sickle cell disease thereof.
    Type: Application
    Filed: February 27, 2018
    Publication date: October 11, 2018
    Inventors: Marshall L. SUMMAR, Frederick W. BARR, Suvankar MAJUMDAR
  • Sequelae of Cardiopulmonary Bypass-Induced Pulmonary Injury
    Publication number: 20180214403
    Abstract: A method for administering citrulline to a patient during surgery without filtration of the hemolysis to reduce the uncoupling of eNOS enzyme dimer that leads to cardiopulmonary bypass-induced pulmonary injury.
    Type: Application
    Filed: December 22, 2017
    Publication date: August 2, 2018
    Inventors: Marshall L. SUMMAR, Frederick W. BARR